Literature DB >> 34981497

Antitumor and Protective Effects of Melatonin: The Potential Roles of MicroRNAs.

Milad Ashrafizadeh1,2, Zahra Ahmadi3, Habib Yaribeygi4, Thozhukat Sathyapalan5, Tannaz Jamialahmadi6,7, Amirhossein Sahebkar8,9,10.   

Abstract

MicroRNAs (miRNAs) are endogenous short noncoding RNAs with approximately 22 nucleotides. The primary function of miRNAs is the negative regulation of target gene expression via mRNA degradation or translation inhibition. During recent years, much attention has been made toward miRNAs' role in different disorders; particularly cancer and compounds with modulatory effects on miRNAs are of interest. Melatonin is one of these compounds which is secreted by the pineal gland. Also, melatonin is present in the leaves, fruits, and seeds of plants. Melatonin has several valuable biological activities such as antioxidant, anti-inflammation, antitumor, and antiaging activities. This important agent is extensively used to treat different disorders such as cancer and neurodegenerative and cardiovascular diseases. This review aims to describe the modulatory effect of melatonin on miRNAs as novel targets.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Cancer; Melatonin; MicroRNAs; Noncoding RNAs; Therapeutic

Mesh:

Substances:

Year:  2021        PMID: 34981497     DOI: 10.1007/978-3-030-73234-9_31

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  62 in total

1.  Transcriptome-wide discovery of microRNA binding sites in human brain.

Authors:  Ryan L Boudreau; Peng Jiang; Brian L Gilmore; Ryan M Spengler; Rebecca Tirabassi; Jay A Nelson; Christopher A Ross; Yi Xing; Beverly L Davidson
Journal:  Neuron       Date:  2014-01-02       Impact factor: 17.173

Review 2.  Slicing tRNAs to boost functional ncRNA diversity.

Authors:  Jennifer Gebetsberger; Norbert Polacek
Journal:  RNA Biol       Date:  2013-11-21       Impact factor: 4.652

Review 3.  MicroRNA: A novel target of curcumin in cancer therapy.

Authors:  Hamed Mirzaei; Aria Masoudifar; Amirhossein Sahebkar; Naser Zare; Javid Sadri Nahand; Bahman Rashidi; Emadodin Mehrabian; Mohsen Mohammadi; Hamid Reza Mirzaei; Mahmoud Reza Jaafari
Journal:  J Cell Physiol       Date:  2017-08-03       Impact factor: 6.384

Review 4.  MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment.

Authors:  Habib Yaribeygi; Niki Katsiki; Behzad Behnam; Helia Iranpanah; Amirhossein Sahebkar
Journal:  Metabolism       Date:  2018-07-03       Impact factor: 8.694

Review 5.  MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy.

Authors:  Hamed Mirzaei; Fatemeh Momeni; Leila Saadatpour; Amirhossein Sahebkar; Mohammad Goodarzi; Aria Masoudifar; Shirin Kouhpayeh; Hossein Salehi; Hamid Reza Mirzaei; Mahmoud Reza Jaafari
Journal:  J Cell Physiol       Date:  2017-06-22       Impact factor: 6.384

Review 6.  Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches.

Authors:  Julia Beermann; Maria-Teresa Piccoli; Janika Viereck; Thomas Thum
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

Review 7.  MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer.

Authors:  Abdullah Moridikia; Hamed Mirzaei; Amirhossein Sahebkar; Jafar Salimian
Journal:  J Cell Physiol       Date:  2017-05-15       Impact factor: 6.384

8.  Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA.

Authors:  A E Pasquinelli; B J Reinhart; F Slack; M Q Martindale; M I Kuroda; B Maller; D C Hayward; E E Ball; B Degnan; P Müller; J Spring; A Srinivasan; M Fishman; J Finnerty; J Corbo; M Levine; P Leahy; E Davidson; G Ruvkun
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

9.  Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.

Authors:  Alfredo Castello; Bernd Fischer; Katrin Eichelbaum; Rastislav Horos; Benedikt M Beckmann; Claudia Strein; Norman E Davey; David T Humphreys; Thomas Preiss; Lars M Steinmetz; Jeroen Krijgsveld; Matthias W Hentze
Journal:  Cell       Date:  2012-05-31       Impact factor: 41.582

Review 10.  Therapeutic targeting of non-coding RNAs in cancer.

Authors:  Ondrej Slaby; Richard Laga; Ondrej Sedlacek
Journal:  Biochem J       Date:  2017-12-14       Impact factor: 3.857

View more
  1 in total

1.  Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer's disease.

Authors:  Dongmei Chen; Guihua Lan; Ruomeng Li; Yingxue Mei; Xindong Shui; Xi Gu; Long Wang; Tao Zhang; Chen-Ling Gan; Yongfang Xia; Li Hu; Yuan Tian; Mi Zhang; Tae Ho Lee
Journal:  Transl Neurodegener       Date:  2022-05-09       Impact factor: 9.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.